<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02956057</url>
  </required_header>
  <id_info>
    <org_study_id>BN102016</org_study_id>
    <nct_id>NCT02956057</nct_id>
  </id_info>
  <brief_title>Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy</brief_title>
  <official_title>A Head-to-head Comparison of Efficiency and Tolerance of 4-L Polyethylene Glycol and Sodium Picosulphate/ Magnesium Citrate, Polyethylene Glycol/Ascorbate Before Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tomas Bata Hospital, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Faculty Hospital Kralovske Vinohrady</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tomas Bata Hospital, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study evaluates the efficacy and tolerability of low volume preparations compared with&#xD;
      conventional 4L polyethylene glycol prior to colonoscopy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the efficacy and tolerance of standard polyethylene glycol to low volume sodium&#xD;
      picosulphate/magnesium citrate and polyethylene glycol/ascorbic acid in a single or split&#xD;
      dose regimen for colonoscopy bowel preparation in a head-to-head design.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 12, 2016</start_date>
  <completion_date type="Actual">August 17, 2017</completion_date>
  <primary_completion_date type="Actual">May 29, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)</measure>
    <time_frame>One day</time_frame>
    <description>Bowel preparation score 1+2 expressed on Aronchick scale (1 the best, 5 the worst)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)</measure>
    <time_frame>One day</time_frame>
    <description>Tolerance of Bowel Preparation Assessed by VAS score 1+2 ( 1-excellent, 5-very poor)</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">1044</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>PEG1D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyethylene glycols single dose a day before colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEG2D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyethylene glycols split dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPMC1D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPMC2D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Natrium picosulfate/ Magnesium citrate split dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEGA1D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEGA2D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyethylene glycol / Ascorbic acid split dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene Glycols</intervention_name>
    <arm_group_label>PEG1D</arm_group_label>
    <arm_group_label>PEG2D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Natrium picosulfate / Magnesium citrate</intervention_name>
    <arm_group_label>SPMC1D</arm_group_label>
    <arm_group_label>SPMC2D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene glycol / Ascorbic acid</intervention_name>
    <arm_group_label>PEGA1D</arm_group_label>
    <arm_group_label>PEGA2D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects referred to diagnostic or therapeutic colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ileus&#xD;
&#xD;
          -  known or suspected bowel obstruction&#xD;
&#xD;
          -  active bowel inflammation&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  any presence of serious medical conditions&#xD;
&#xD;
          -  history of prior colonic or rectal surgery&#xD;
&#xD;
          -  inability to obtain valid data from subject&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Kojecky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemocnice T.Bati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty Hospital Kralovske Vinohrady</name>
      <address>
        <city>Prague</city>
        <zip>10024</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <reference>
    <citation>Kojecky V, Matous J, Keil R, Dastych M, Kroupa R, Zadorova Z, Varga M, Dolina J, Kment M, Hep A. A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial. Int J Colorectal Dis. 2017 Dec;32(12):1763-1766. doi: 10.1007/s00384-017-2901-x. Epub 2017 Sep 24.</citation>
    <PMID>28944412</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 1, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2016</study_first_posted>
  <results_first_submitted>October 6, 2019</results_first_submitted>
  <results_first_submitted_qc>October 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 28, 2020</results_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tomas Bata Hospital, Czech Republic</investigator_affiliation>
    <investigator_full_name>Vladimir Kojecky, MD, Ph.D.</investigator_full_name>
    <investigator_title>MUDr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Magnesium citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 3, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT02956057/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PEG1D</title>
          <description>Polyethylene glycols single dose a day before colonoscopy&#xD;
Polyethylene Glycols</description>
        </group>
        <group group_id="P2">
          <title>PEG2D</title>
          <description>Polyethylene glycols split dose&#xD;
Polyethylene Glycols</description>
        </group>
        <group group_id="P3">
          <title>SPMC1D</title>
          <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy&#xD;
Natrium picosulfate / Magnesium citrate</description>
        </group>
        <group group_id="P4">
          <title>SPMC2D</title>
          <description>Natrium picosulfate/ Magnesium citrate split dose&#xD;
Natrium picosulfate / Magnesium citrate</description>
        </group>
        <group group_id="P5">
          <title>PEGA1D</title>
          <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy&#xD;
Polyethylene glycol / Ascorbic acid</description>
        </group>
        <group group_id="P6">
          <title>PEGA2D</title>
          <description>Polyethylene glycol / Ascorbic acid split dose&#xD;
Polyethylene glycol / Ascorbic acid</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="174"/>
                <participants group_id="P2" count="174"/>
                <participants group_id="P3" count="174"/>
                <participants group_id="P4" count="174"/>
                <participants group_id="P5" count="174"/>
                <participants group_id="P6" count="174"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="160"/>
                <participants group_id="P2" count="162"/>
                <participants group_id="P3" count="166"/>
                <participants group_id="P4" count="159"/>
                <participants group_id="P5" count="169"/>
                <participants group_id="P6" count="157"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Discontinued intervention</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PEG1D</title>
          <description>Polyethylene glycols single dose a day before colonoscopy</description>
        </group>
        <group group_id="B2">
          <title>PEG2D</title>
          <description>Polyethylene glycols split dose</description>
        </group>
        <group group_id="B3">
          <title>SPMC1D</title>
          <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy</description>
        </group>
        <group group_id="B4">
          <title>SPMC2D</title>
          <description>Natrium picosulfate/ Magnesium citrate split dose</description>
        </group>
        <group group_id="B5">
          <title>PEGA1D</title>
          <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy</description>
        </group>
        <group group_id="B6">
          <title>PEGA2D</title>
          <description>Polyethylene glycol / Ascorbic acid split dose</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="160"/>
            <count group_id="B2" value="162"/>
            <count group_id="B3" value="166"/>
            <count group_id="B4" value="159"/>
            <count group_id="B5" value="169"/>
            <count group_id="B6" value="157"/>
            <count group_id="B7" value="973"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.9" spread="15.3"/>
                    <measurement group_id="B2" value="64.5" spread="13.9"/>
                    <measurement group_id="B3" value="60.8" spread="16.1"/>
                    <measurement group_id="B4" value="63.1" spread="13.1"/>
                    <measurement group_id="B5" value="60.1" spread="14.3"/>
                    <measurement group_id="B6" value="60.6" spread="17.0"/>
                    <measurement group_id="B7" value="62.1" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="81"/>
                    <measurement group_id="B4" value="77"/>
                    <measurement group_id="B5" value="67"/>
                    <measurement group_id="B6" value="67"/>
                    <measurement group_id="B7" value="429"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="85"/>
                    <measurement group_id="B4" value="82"/>
                    <measurement group_id="B5" value="102"/>
                    <measurement group_id="B6" value="90"/>
                    <measurement group_id="B7" value="544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="159"/>
                    <measurement group_id="B5" value="169"/>
                    <measurement group_id="B6" value="157"/>
                    <measurement group_id="B7" value="973"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Czechia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="159"/>
                    <measurement group_id="B5" value="169"/>
                    <measurement group_id="B6" value="157"/>
                    <measurement group_id="B7" value="973"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)</title>
        <description>Bowel preparation score 1+2 expressed on Aronchick scale (1 the best, 5 the worst)</description>
        <time_frame>One day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PEG1D</title>
            <description>Polyethylene glycols single dose a day before colonoscopy</description>
          </group>
          <group group_id="O2">
            <title>PEG2D</title>
            <description>Polyethylene glycols split dose</description>
          </group>
          <group group_id="O3">
            <title>SPMC1D</title>
            <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy</description>
          </group>
          <group group_id="O4">
            <title>SPMC2D</title>
            <description>Natrium picosulfate/ Magnesium citrate split dose</description>
          </group>
          <group group_id="O5">
            <title>PEGA1D</title>
            <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy</description>
          </group>
          <group group_id="O6">
            <title>PEGA2D</title>
            <description>Polyethylene glycol / Ascorbic acid split dose</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)</title>
          <description>Bowel preparation score 1+2 expressed on Aronchick scale (1 the best, 5 the worst)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
                <count group_id="O2" value="162"/>
                <count group_id="O3" value="166"/>
                <count group_id="O4" value="159"/>
                <count group_id="O5" value="169"/>
                <count group_id="O6" value="157"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                    <measurement group_id="O2" value="145"/>
                    <measurement group_id="O3" value="100"/>
                    <measurement group_id="O4" value="134"/>
                    <measurement group_id="O5" value="121"/>
                    <measurement group_id="O6" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)</title>
        <description>Tolerance of Bowel Preparation Assessed by VAS score 1+2 ( 1-excellent, 5-very poor)</description>
        <time_frame>One day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PEG1D</title>
            <description>Polyethylene glycols single dose a day before colonoscopy</description>
          </group>
          <group group_id="O2">
            <title>PEG2D</title>
            <description>Polyethylene glycols split dose</description>
          </group>
          <group group_id="O3">
            <title>SPMC1D</title>
            <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy</description>
          </group>
          <group group_id="O4">
            <title>SPMC2D</title>
            <description>Natrium picosulfate/ Magnesium citrate split dose</description>
          </group>
          <group group_id="O5">
            <title>PEGA1D</title>
            <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy</description>
          </group>
          <group group_id="O6">
            <title>PEGA2D</title>
            <description>Polyethylene glycol / Ascorbic acid split dose</description>
          </group>
        </group_list>
        <measure>
          <title>Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)</title>
          <description>Tolerance of Bowel Preparation Assessed by VAS score 1+2 ( 1-excellent, 5-very poor)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
                <count group_id="O2" value="162"/>
                <count group_id="O3" value="166"/>
                <count group_id="O4" value="159"/>
                <count group_id="O5" value="169"/>
                <count group_id="O6" value="157"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="134"/>
                    <measurement group_id="O4" value="139"/>
                    <measurement group_id="O5" value="85"/>
                    <measurement group_id="O6" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>0</time_frame>
      <desc>AE not assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>PEG1D</title>
          <description>Polyethylene glycols single dose a day before colonoscopy</description>
        </group>
        <group group_id="E2">
          <title>PEG2D</title>
          <description>Polyethylene glycols split dose</description>
        </group>
        <group group_id="E3">
          <title>SPMC1D</title>
          <description>Natrium picosulfate/ Magnesium citrate single dose day before colonoscopy</description>
        </group>
        <group group_id="E4">
          <title>SPMC2D</title>
          <description>Natrium picosulfate/ Magnesium citrate split dose</description>
        </group>
        <group group_id="E5">
          <title>PEGA1D</title>
          <description>Polyethylene glycol / Ascorbic acid single dose day before colonoscopy</description>
        </group>
        <group group_id="E6">
          <title>PEGA2D</title>
          <description>Polyethylene glycol / Ascorbic acid split dose</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kojecky Vladimir</name_or_title>
      <organization>Tomas Bata Hospital</organization>
      <phone>+420577552512</phone>
      <email>kojecky@bnzlin.cz</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

